Company Overview
FMC Corporation operates as a global agricultural sciences company dedicated to the development, marketing, and sale of crop protection chemicals across Latin America, North America, Europe, the Middle East, Africa, and Asia. The firm's portfolio specifically includes insecticides, herbicides, and fungicides designed to safeguard agricultural yields in these diverse geographic regions. This entity functions within the Basic Materials sector, specifically targeting the Agricultural Inputs industry, which implies a critical role in supporting global food production systems through chemical solutions. The company demonstrates a substantial operational scale with a market capitalization of $1.97B, annual revenue of $3.47B, and an employee base of 5500. These valuation and revenue figures indicate that FMC holds a significant position as a mid-sized player in the agricultural input market, possessing the capacity to influence regional supply chains while maintaining a substantial workforce to execute its global distribution strategy.
Financial Health
The company reported a trailing twelve-month revenue of $3.47B, yet posted a net income of -$2,203,399,936, while generating an EBITDA of $413.80M. The stark disparity between the massive revenue figure and the negative net income reveals a cost structure where operating expenses, interest, taxes, and other non-EBITDA charges severely erode bottom-line profitability, resulting in a profit margin of -64.6%. Despite the negative net income, the firm maintains a free cash flow of $94.78M, which suggests a degree of financial flexibility to fund operations or strategic initiatives despite the accounting losses. The gross margin stands at 33.8%, indicating that the company retains over one-third of its sales revenue after direct production costs, while the operating margin of 9.5% shows that overhead and administrative costs consume a significant portion of gross profits. In contrast to the healthy gross margin, the negative profit margin highlights the intensity of non-operating expenses or tax impacts affecting the final earnings. Regarding liquidity and leverage, the company holds $584.50M in cash against total debt of $4.20B, resulting in a debt-to-equity ratio of 200.05, which characterizes a highly leveraged balance sheet where debt obligations substantially exceed equity value. However, the current ratio of 1.32 indicates that the company possesses sufficient current assets to cover its short-term liabilities, providing a buffer for immediate financial obligations. Return on Equity is recorded at -66.6% and Return on Assets at 1.4%, metrics that collectively reveal significant challenges in management effectiveness, as the company is currently unable to generate positive returns on shareholder investments or its overall asset base.
Valuation Assessment
The valuation metrics present a complex picture with a P/E Ratio (TTM) listed as N/A due to negative earnings, while the Forward P/E stands at 7.02. The absence of a trailing P/E versus the existence of a forward P/E implies that the market is pricing in an expectation of future earnings recovery or a change in the current loss trajectory. The price-to-book ratio is 0.95, indicating that the market is valuing the company at approximately 95% of its book value, which suggests no market premium and potentially a discount relative to the underlying asset value. Alternative valuation metrics include a price-to-sales ratio of 0.57 and an EV/EBITDA of 13.56, which suggest the market is willing to pay a moderate multiple relative to sales and earnings before interest, taxes, depreciation, and amortization. Price metrics show a 52-Week High of $44.78 and a 52-Week Low of $12.17, providing the range within which the stock has traded over the last year. Without the specific current share price provided in the facts, the exact percentage below the high cannot be calculated, but the wide range between $12.17 and $44.78 indicates significant volatility in the stock's recent trading history. The stock exhibits a Beta of 0.65, which means the price volatility is lower than the broader market, suggesting the asset moves less aggressively than the overall market index during periods of fluctuation.
Growth & Income
The revenue growth year-over-year is -11.5%, while the earnings growth is N/A due to the current negative net income. The contraction in revenue combined with the absence of positive earnings growth indicates that the company is currently facing headwinds in both top-line sales and bottom-line profitability, preventing any acceleration in earnings relative to revenue. Regarding income distribution, the company offers a dividend yield of 2.0%, supported by a payout ratio of 223.1%. This payout ratio is unsustainable given the negative net income, as the company is paying out dividends on earnings it has not generated, which relies on cash reserves or debt accumulation to maintain the yield. Consequently, the firm is effectively reinvesting earnings into growth or maintaining dividend levels through other means rather than distributing organic profits. The overall growth and income profile is characterized by a period of revenue contraction and negative earnings, supported by a high-yield but mathematically unsustainable dividend payment that contrasts sharply with the current financial performance.